Table 1 of Strzalka-Mrozik, Mol Vis 2010; 16:1272-1279.


Table 1. Selected clinical features and biochemical markers of type 2 diabetus mellitus (DM) patients and controls

Characteristic Type 2 DM (n=58) Controls (n=60)
Gender
M 21 33
F 37 27
Age (year) 60.0 (42.0–83.0) 61.0 (52.0–76.0)
BMI (kg/m2) 29.4 (22.0–44.0) 27.0 (21.0–32.0)
BMI
Normal 9 24
Overweight 23 24
Obese 26 12
Smoking
Yes 6 0
No 52 60
Arterial hypertension
Yes 40 4
No 18 56
*Glycemia 142.5 (69.0–387.0) 100.0 (89.0–108.0)
*Serum creatinine 0.9 (0.5–1.1) 1.2 (0.9–1.1)
*Total cholesterol 193.0 (139.0–326.0) 220.0 (184.0–267.0)
*Triglycerides 158.0 (69.0–343.0) 110.0 (86.0–193.0)
*HDL cholesterol 49.5 (40.0–64.0) 65.0 (47.0–128.0)
*LDL cholesterol 125.5 (100.0–20.0) 147.0 (52.0–199.0)
Glycosylated hemoglobin (%) 7.5 (5.3–9.8) -
Length of clinical course (year) 10.5 (1.0–29.0) -
Type of retinopathy
No DR 19 -
NPDR 28 -
PDR 11 -
Diabetic macular edema
Yes 0 -
No 58 -
Frequency of glycemic control
Less than once daily 14 -
Once daily 14 -
Twice daily 13 -
Thrice daily 17 -
Insulin therapy
Yes 31 -
No 27 -
Length of insulin therapy (years) 7.0 (0–25.0) -
Medication with oral anti-diabetic drugs
Yes 44 -
No 14 -
Type of the anti-diabetic drug
Metformin 36 -
Sulfonylureas 24 -
Alpha-glucosidase inhibitor 6 -
Type of anti-hypertensive drug
β-blocker 13 -
Ca-blocker 11 -
ACE inhibitor 29 -
Diuretics 12 -